Hyundai announced it will start distributing free CCS to Tesla NACS adapters to its EV customers in the first quarter of 2025. The adapters will enable vehicles such as the Ioniq 5 and Ioniq 6 to ...

Pfizer is seeing a strong uptick in Vyndaqel and Abrysvo and a continued growth in Eliquis has aided the overall sales growth lately. Vyndaqel sales were up 66% y-o-y to $3.9 billion for the nine ...

Recent advances have resulted in clinical options to offer high-risk patients: AREXY ®, mRESVIA ®, and ABRYSVO ® for people ages 60 and older; ABRYSVO ® for pregnant women at 32 to 36 weeks gestation; ...

Pfizer is seeing a strong uptick in Vyndaqel and Abrysvo and a continued growth in Eliquis has aided the overall sales growth lately. Vyndaqel sales were up 66% y-o-y to $3.9 billion for the nine ...

Pfizer’s PFE RSV vaccine, Abrysvo, was launched to help protect older adults as well as infants through maternal immunization in the United States as well as in the EU in 2023. PFE’s Abrysvo ...

Even though an increasing number of PCs now have Wi-Fi connectivity built into their motherboards, you may find that the connection isn't great, and an external USB wireless adaptor can help ...

Pfizer is also at the beginning of the critical—and competitive—launch of the respiratory syncytial virus (RSV) vaccine Abrysvo. A recent CDC restriction on RSV vaccinations already showed ...

Beyfortus can be used in infants who are entering their first or second RSV season, while Pfizer’s vaccine Abrysvo can be given to pregnant women to pass on passive immunity to their newborns.

Pfizer's internal research and development (R&D) is also paying off, with respiratory syncytial virus vaccine Abrysvo's 53% market share a case in point. Meanwhile, Pfizer offers one of the most ...

A pediatric vaccine for respiratory syncytial virus (RSV) is proving to be elusive, according to news from the U.S. Food and Drug Administration. RSV is a highly contagious, common respiratory ...